SEC EDGAR Filing Information

Form 4 -- Statement of changes in beneficial ownership of securities

Period of Report: 2007-09-27
Filing Date Changed: 2007-10-01
Documents: 1

SEC Accession No.
0001140361-07-018882
Filing date: 2007-10-01
Accepted: 2007-10-01 16:02:24

Table of submitted documents:

Seq	Type	Document	Size	Description
1	4	doc1.html		FORM 4
1	4	doc1.xml	5162	FORM 4

		0001140361-07-018882.txt	7170	Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Issuer) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
1101 BRICKELL AVENUE
SUITE 701 S
MIAMI FL 33131
305-534-3383

Mailing Address
1101 BRICKELL AVENUE
SUITE 701 S
MIAMI FL 33131

Buhrman Cyrille F (Reporting) (0001405103)
Type: 4 | Act: 34 | File No.: 000-16929 | Film No.: 071145965

Business Address
786-425-3848

Mailing Address
1101 BRICKELL AVENUE
SUITE 701-S
MIAMI FL 33131